首页> 外文期刊>International Journal of Molecular Sciences >“Nano-Ginseng” for Enhanced Cytotoxicity AGAINST Cancer Cells
【24h】

“Nano-Ginseng” for Enhanced Cytotoxicity AGAINST Cancer Cells

机译:“纳米人参”可增强对抗癌细胞的细胞毒性

获取原文
           

摘要

Panax ginseng has high medicinal and health values. However, the various and complex components of ginseng may interact with each other, thus reducing and even reversing therapeutic effects. In this study, we designed and fabricated a novel “nano-ginseng” with definite ingredients, ginsenoside Rb1/protopanaxadiol nanoparticles (Rb1/PPD NPs), completely based on the protopanaxadiol-type extracts. The optimized nano-formulations demonstrated an appropriate size (~110 nm), high drug loading efficiency (~96.8%) and capacity (~27.9 wt %), long half-time in systemic circulation (nine-fold longer than free PPD), better antitumor effects in vitro and in vivo, higher accumulation at the tumor site and reduced damage to normal tissues. Importantly, this process of “nano-ginseng” production is a simple, scalable, green economy process.
机译:人参具有很高的药用和保健价值。但是,人参的各种复杂成分可能会相互影响,从而降低甚至逆转治疗效果。在这项研究中,我们设计并制造了一种完全基于原托那沙酚型提取物的具有确定成分的人参皂苷Rb1 /原托那沙糖醇纳米粒子(Rb1 / PPD NPs)。优化的纳米制剂具有合适的尺寸(〜110 nm),高载药效率(〜96.8%)和容量(〜27.9 wt%),系统循环中的半衰期长(比游离PPD长九倍),在体内外具有更好的抗肿瘤作用,在肿瘤部位有更高的蓄积性,并减少了对正常组织的损害。重要的是,这种“纳米人参”生产过程是一个简单,可扩展的绿色经济过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号